Reverse genetics often requires systems that allow intended induction of toxic genes or inactivation of vital genes at a chosen moment and/or in a chosen tissue. Cre-lox recombination is a common tool of genetic engineering and is used to conditionally knock out a gene, in which an exon is preliminarily flanked with loxP sites, or to induce expression of a gene, in which a loxP-flanked STOP cassette is preliminarily inserted between the promoter and the open reading frame. A mouse strain, Stra8-Cre/ERT2, was constructed to allow tamoxifen induction of Cre-lox recombination in spermatocytes. Construction was performed using a 400-bp promoter of the Stra8 gene, whose protein product STRA8 initiates the transition from mitosis to meiosis in response to a growing concentration of retinoic acid in the cell. The strain will be further used to study the regulatory mechanisms of meiosis.
Ilchuk et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: